Evidence map›Paper›PMID 9176403›Full record

ArticleThe American journal of pathology1997

Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.

K Hida, M Shindoh, M Yasuda, M Hanzawa, K Funaoka, T Kohgo, A Amemiya, Y Totsuka, K Yoshida, K Fujinaga

Abstract read
In one paragraph

Article in The American journal of pathology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Role of Ets transcription factors in mammary gland development and oncogenesis.Journal of mammary gland biology and neoplasia · 2001
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

K HidaDepartment of Oral Surgery, Hokkaido University School of Dentistry, Japan.
M Shindoh
M Yasuda
M Hanzawa
K Funaoka
T Kohgo
A Amemiya
Y Totsuka
K Yoshida
K Fujinaga
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E1AF is a newly identified human ets-family transcription factor. We have reported that E1AF can up-regulate transcription of matrix metalloproteinase (MMP) genes and confers invasive phenotype on human cancer cells. HSC3 is an oral squamous-cell-carcinoma-derived cell line, and it manifests high levels of E1AF and MMP-1 and -9 gene expression that are associated with invasive potential. We reconstructed an E1AF antisense expression vector, transfected HSC3 cells with the vector, and obtained HSC3AS cells that express E1AF antisense RNA. HSC3AS showed decreasing mRNA and protein levels of MMP-1, -3, and -9. Moreover, HSC3AS showed lower invasive potential in vitro three-dimensional raft culture and in vivo implantation into nude mice. These results imply that transfection of antisense E1AF inhibits tumor invasion by down-regulating MMP genes.

Indexed as

Adenovirus E1A ProteinsAnimalsBlotting, NorthernCarcinoma, Squamous CellCell Culture TechniquesCollagenasesHumansImmunohistochemistryMatrix Metalloproteinase 1Matrix Metalloproteinase 3Matrix Metalloproteinase 9MetalloendopeptidasesMiceMice, NudeMouth NeoplasmsNeoplasm InvasivenessAdenovirus E1A ProteinsCollagenasesETV4 protein, humanMatrix Metalloproteinase 1Matrix Metalloproteinase 3Matrix Metalloproteinase 9MetalloendopeptidasesProto-Oncogene ProteinsProto-Oncogene Proteins c-etsRNA, AntisenseRNA, MessengerTranscription Factors

Identifiers

PMID9176403
PMCPMC1858336
OpenAlexW231086591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.